Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy (Q34175570)

31 July 2017

Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

Guido van Marle

3

0 references

Tomasz I Michalak

series ordinal

5

object named as

Tomasz I Michalak

1 reference

31 July 2017

4

John P Roberts

1 reference

31 July 2017

6

Norah A Terrault

1 reference

31 July 2017

Carla S Coffin

1

1 reference

PubMed ID

21462295

31 July 2017

Patricia M Mulrooney-Cousins

series ordinal

2

1 reference

PubMed ID

21462295

31 July 2017

language of work or name

1 reference

1 August 2011

1 reference

31 July 2017

Liver Transplantation

1 reference

31 July 2017

17

1 reference

31 July 2017

8

1 reference

31 July 2017

955-962

1 reference

Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective

31 July 2017

1 reference

Hepatitis B immune globulin preparations and use in liver transplantation

21 January 2018

1 reference

Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence

21 January 2018

1 reference

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis

21 January 2018

1 reference

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

21 January 2018

1 reference

Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis

21 January 2018

1 reference

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

21 January 2018

1 reference

Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin

21 January 2018

1 reference

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

21 January 2018

1 reference

Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure

21 January 2018

1 reference

Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance

21 January 2018

1 reference

In vitro characterization of viral fitness of therapy-resistant hepatitis B variants

21 January 2018

1 reference

Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

21 January 2018

1 reference

Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis

21 January 2018

1 reference

Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection

21 January 2018

1 reference

Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus

21 January 2018

1 reference

Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine-resistant hepatitis B virus during adefovir therapy

21 January 2018

1 reference

In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus

21 January 2018

1 reference

Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver

21 January 2018

1 reference

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis

21 January 2018

1 reference

Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection

21 January 2018

1 reference

Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LT.22312

1 reference

31 July 2017

1 reference

PubMed ID

21462295